The pattern continues anew.
In early September, a series of unexplained child deaths in a rural community in central India had local medical staff scrambling.
No fewer than eleven victims - aged 1-6 years - succumbed shortly of taking a common cold medicine. Authorities tested everything from tap water to mosquitoes before the truth emerged: their kidneys had stopped functioning.
After investigation, a government testing facility in southern India verified the most alarming finding. The medicine in question was found to have nearly half toxic solvent, a poisonous chemical that should never be present in medicine. Kidney failure is frequent after ingesting this poisonous alcohol.
Broadening Crisis
The tragedy wasn't confined to Madhya Pradesh. In neighbouring another Indian state, the fatalities of a pair of small kids, allegedly after consuming a locally-made Dextromethorphan syrup - medication unsafe for very young children - sparked public anger and a official probe.
Across the nation, this caused a disturbing feeling of déjà vu.
In recent times, the toxic chemical in domestically produced cough syrups has taken dozens of young lives. In 2023, Indian syrups tainted with diethylene glycol were linked to the deaths of seventy children in Africa and eighteen in Uzbekistan.
Between late 2019 and January 2020, no fewer than twelve children below five years succumbed in northern India reportedly from medication, with activists indicating the total of victims might have been greater. In the past, there's also been misuse of medicines with an opioid, a mild opioid that can produce pleasure in large quantities and cause dependence, and is discouraged for young children.
Regulatory Shortcomings
Whenever authorities vow reform, tainted syrups resurface - reflecting a disjointed pharmaceutical industry and, experts claim, a weak regulatory system struggling to oversee hundreds of cheap, frequently unauthorized medications produced by local companies and available over the counter.
Days after the latest child deaths, India's health ministry urged appropriate use of such drugs - effectively cautioning doctors to exercise more care when prescribing them to young children - confiscated batches of the medicine, halted and banned distribution, and initiated an inquiry.
Industry Expansion and Medical Reality
But the issue, experts argue, runs deeper than over-prescription. Each new incident exposes the flaws in the country's pharmaceutical regulation framework - a maze of poor enforcement and control. The Indian cold medicine industry is projected to grow significantly from over two hundred million dollars in this year to nearly three quarters of a billion dollars by the next decade, growing at a compound annual rate of almost ten percent, according to market research.
Yet none of this would happen if the nation, and its citizens, could reduce their obsession with cold medications. For decades, doctors have recommended them, and users have taken them, even though the majority do little good and can potentially cause significant damage.
Marketed as quick relief for sore throats and stubborn coughs, these flavored syrups combine sugar, colour and flavorings with a combination of allergy medications, nasal openers, mucus thinners.
Medical Viewpoint
In theory, each ingredient has a function: one dries secretions, others loosens phlegm, a third dulls the coughing impulse. Realistically, research of them doing much good is small - most respiratory issues get better on their own in a short time.
A cough can be caused by either infection or an immune response. Cold medications broadly fall into two categories - sedatives that enable the youngster sleep, and bronchodilators that ease breathing - and doctors usually recommend one or the other, not a combination.
Most persistent respiratory issues in kids in heavily contaminated Indian cities are unrelated to illness but by allergies and irritation of the lower airways, according to children's doctors. Hypersensitivity reactions occur when the immune system overreacts to triggers such as particles and pollution.
These youngsters frequently have a runny nose and a respiratory issue that intensifies at night or dawn, recurring every few weeks. In big cities, such repeating, wet coughs are commonly caused by dust and smog, sometimes combined with mild bronchospasm.
Management Approaches
Medical professionals said such coughs are most effectively treated with airway medications - treatments that expand the airways - ideally through inhalers or mist devices, though many physicians still rely on syrups that offer only minimal relief.
The majority of pediatric coughs are viral, self-limiting, and clear on their own within a few days. Physicians say no syrup shortens their duration; at best, they provide temporary comfort. At worst, they pose dangers of dependency, poisoning and excessive consumption.
"I don't usually recommend cough syrups for common symptoms and respiratory infections - except sometimes for comfort. If a youngster is severely symptomatic and can't sleep, I might administer a small amount of a gentle medication just to ease the symptoms. The main goal is comfort, not cure, especially when the symptom is dry and associated with a common illness," says a pediatric specialist.
Underlying Issues
What explains are cough syrups so widely prescribed in India?
One reason is the deficiency of the nation's primary healthcare system, especially in rural communities and rural areas. As increasing environmental contaminants fuels chronic respiratory issues, they are increasingly overused for routine respiratory infections.
This issue is more severe in the rural regions. In rural India, up to three-quarters of primary care consultations are managed by informal providers - often untrained rural medical practitioners lacking formal medical training.
In locations where the local public health clinic is far away, under-staffed, or closed, they are the actual doctors - and syrups are their primary treatments. When working in a northern town, a
